CA2910877C - Expression process - Google Patents

Expression process Download PDF

Info

Publication number
CA2910877C
CA2910877C CA2910877A CA2910877A CA2910877C CA 2910877 C CA2910877 C CA 2910877C CA 2910877 A CA2910877 A CA 2910877A CA 2910877 A CA2910877 A CA 2910877A CA 2910877 C CA2910877 C CA 2910877C
Authority
CA
Canada
Prior art keywords
chinese hamster
target polypeptide
hamster ovary
sequence
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2910877A
Other languages
English (en)
French (fr)
Other versions
CA2910877A1 (en
Inventor
Fay Louise SAUNDERS
Anna Louise DODDS
Adeline Marie Geraldine BAYARD
Bhupendra Vallabh Kara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Diosynth Biotechnologies UK Ltd
Original Assignee
Fujifilm Diosynth Biotechnologies UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201308017A external-priority patent/GB201308017D0/en
Priority claimed from GB201320339A external-priority patent/GB201320339D0/en
Application filed by Fujifilm Diosynth Biotechnologies UK Ltd filed Critical Fujifilm Diosynth Biotechnologies UK Ltd
Publication of CA2910877A1 publication Critical patent/CA2910877A1/en
Application granted granted Critical
Publication of CA2910877C publication Critical patent/CA2910877C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • C07K16/3092—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated mucins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
CA2910877A 2013-05-03 2014-04-29 Expression process Active CA2910877C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB201308017A GB201308017D0 (en) 2013-05-03 2013-05-03 Expression process
GB1308017.1 2013-05-03
GB201320339A GB201320339D0 (en) 2013-11-18 2013-11-18 Expression Process
GB1320339.3 2013-11-18
PCT/GB2014/000165 WO2014177826A1 (en) 2013-05-03 2014-04-29 Expression process

Publications (2)

Publication Number Publication Date
CA2910877A1 CA2910877A1 (en) 2014-11-06
CA2910877C true CA2910877C (en) 2021-08-03

Family

ID=50639794

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2910877A Active CA2910877C (en) 2013-05-03 2014-04-29 Expression process

Country Status (12)

Country Link
US (3) US9873891B2 (cg-RX-API-DMAC10.html)
EP (1) EP2992104B1 (cg-RX-API-DMAC10.html)
JP (1) JP6545153B2 (cg-RX-API-DMAC10.html)
KR (1) KR102180660B1 (cg-RX-API-DMAC10.html)
CN (2) CN105392889A (cg-RX-API-DMAC10.html)
BR (1) BR112015027373A2 (cg-RX-API-DMAC10.html)
CA (1) CA2910877C (cg-RX-API-DMAC10.html)
DK (1) DK2992104T3 (cg-RX-API-DMAC10.html)
ES (1) ES2732907T3 (cg-RX-API-DMAC10.html)
RU (1) RU2731717C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201508447TA (cg-RX-API-DMAC10.html)
WO (1) WO2014177826A1 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3323826A1 (en) * 2016-11-21 2018-05-23 Danmarks Tekniske Universitet Native chinese hamster ovary cell secretion signal peptides for production of recombinant polypeptides
EP3725877A4 (en) 2017-12-11 2021-02-17 FUJIFILM Corporation ANIMAL CELLS AS WELL AS A METHOD FOR MANUFACTURING THE SAME, AND A METHOD FOR MANUFACTURING TARGET PROTEIN
JP7123168B2 (ja) 2018-12-11 2022-08-22 富士フイルム株式会社 動物細胞、動物細胞の製造方法および目的タンパク質の製造方法
CN109837277A (zh) * 2019-03-01 2019-06-04 深圳生生凡非基因技术有限公司 一种cpgk嵌合型启动子、腺相关病毒载体及其应用
JP7352650B2 (ja) 2019-11-29 2023-09-28 富士フイルム株式会社 細胞培養方法、抗体製造方法、有機酸除去方法、及び、抗体
EP4276167A1 (en) 2021-01-07 2023-11-15 FUJIFILM Corporation Cell selection method, device and device system
WO2022196710A1 (ja) 2021-03-17 2022-09-22 富士フイルム株式会社 細胞培養方法、及び有用物質の製造方法
CN112980852B (zh) * 2021-05-18 2021-08-13 北京华芢生物技术有限公司 新型冠状病毒b.1.351南非突变株rbd的基因及其应用
MX2023014069A (es) 2021-05-27 2024-03-15 Janssen Biotech Inc Composiciones y métodos para el tratamiento del cáncer de próstata.
WO2023054556A1 (ja) 2021-09-30 2023-04-06 富士フイルム株式会社 細胞培養方法、及び有用物質の製造方法
CN118541491A (zh) 2021-12-15 2024-08-23 富士胶片株式会社 产物的制造方法及细胞培养装置
JPWO2023190300A1 (cg-RX-API-DMAC10.html) 2022-03-28 2023-10-05
EP4502149A4 (en) 2022-03-31 2026-03-11 Fujifilm Corp PRODUCT MANUFACTURING PROCESS AND PRODUCT
CN119654417A (zh) 2022-06-10 2025-03-18 富士胶片戴奥辛思生物技术英国有限公司 细胞的制备方法、异源多聚体蛋白质的制造方法、双特异性抗体的制造方法、载体组、哺乳动物细胞、cho细胞和细胞池的制备方法
JPWO2024071373A1 (cg-RX-API-DMAC10.html) 2022-09-29 2024-04-04
JPWO2024248120A1 (cg-RX-API-DMAC10.html) 2023-05-31 2024-12-05
EP4722338A1 (en) 2023-05-31 2026-04-08 FUJIFILM Corporation Cell culture method and product producing method
CN121175432A (zh) 2023-05-31 2025-12-19 富士胶片株式会社 生产物的生产方法
WO2025244971A1 (en) 2024-05-20 2025-11-27 Janssen Biotech, Inc. Compositions and methods for the treatment of prostate cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7071172B2 (en) * 2002-04-30 2006-07-04 The University Of North Carolina At Chapel Hill Secretion signal vectors
US7186699B2 (en) * 2003-06-03 2007-03-06 Cell Genesys, Inc. Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
EP1739179A1 (en) * 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
GB0602173D0 (en) * 2006-02-03 2006-03-15 Avecia Ltd Expression system
ES2474940T3 (es) * 2006-12-28 2014-07-10 Janssen Biotech, Inc. Métodos y vectores que generan inmunoglobulinas sialiladas
KR101618767B1 (ko) * 2008-09-02 2016-05-09 한국생명공학연구원 외래단백질을 고효율로 생산하는 리더서열
ES2740051T3 (es) * 2008-12-31 2020-02-05 Bharat Serums & Vaccines Ltd Anticuerpos monoclonales anti-RHD
NZ594514A (en) 2009-03-05 2013-06-28 Abbott Lab Interleukin-17 BINDING PROTEINS
GB0905331D0 (en) * 2009-03-27 2009-05-13 Avecia Biolog Ltd Expression process
KR101420274B1 (ko) * 2011-06-13 2014-07-21 주식회사 종근당 Ｃｓｐ－ｂ ５＇ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법

Also Published As

Publication number Publication date
RU2731717C2 (ru) 2020-09-08
RU2015151626A (ru) 2017-06-08
KR102180660B1 (ko) 2020-11-19
KR20160003705A (ko) 2016-01-11
JP2016517691A (ja) 2016-06-20
CN114395584B (zh) 2025-01-28
CN114395584A (zh) 2022-04-26
CN105392889A (zh) 2016-03-09
ES2732907T3 (es) 2019-11-26
RU2015151626A3 (cg-RX-API-DMAC10.html) 2018-03-20
US9873891B2 (en) 2018-01-23
BR112015027373A2 (pt) 2017-08-29
SG11201508447TA (en) 2015-11-27
WO2014177826A1 (en) 2014-11-06
CA2910877A1 (en) 2014-11-06
EP2992104B1 (en) 2019-04-17
JP6545153B2 (ja) 2019-07-17
US20220213500A1 (en) 2022-07-07
US20180127777A1 (en) 2018-05-10
EP2992104A1 (en) 2016-03-09
US20160076051A1 (en) 2016-03-17
DK2992104T3 (da) 2019-07-15
US11306323B2 (en) 2022-04-19

Similar Documents

Publication Publication Date Title
US20220213500A1 (en) Expression Process
US10611831B2 (en) Production cell line enhancers
JP7410983B2 (ja) Ｃｒｅ ｍＲＮＡを使用した標的指向性組込みによるタンパク質発現細胞の作製のための方法
JP7446342B2 (ja) 所定の構成の複数の発現カセットの標的化組込みによって三価の抗体を発現する細胞を生成するための方法
JP7572977B2 (ja) 所定の構成の複数の発現カセットの標的化組込みによって多価の多重特異性抗体発現細胞を作製するための方法
CA3141039A1 (en) Mammalian cell lines with sirt-1 gene knockout
US9845475B2 (en) Expression vector
JP7856785B2 (ja) 哺乳動物細胞における選択マーカーとしての細菌グルタミン合成酵素
CN120322561A (zh) 新型转座酶系统
EP2922962B1 (en) Optimized expression cassette for expressing a polypeptide with high yield
US20250282894A1 (en) Expression technology for antibody constructs
WO2015033086A1 (en) Dna construct
WO2026103863A1 (en) Signal peptide and use thereof
US20250361524A1 (en) Method for producing cells, method for producing heteromultimeric protein, method for producing bispecific antibody, and method for producing vector set, mammalian cells, CHO cells, and cell pool
CN104558180A (zh) 靶向t淋巴细胞的人源单链抗体
HK40061338A (en) Mammalian cell lines with sirt-1 gene knockout
HK40007802A (en) Production of seleno-biologics in genomically recoded organisms

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190429

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250417

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250417

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260416

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260416